Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 31, 2025Mar 31 8:20 PMLyon Joseph Douglas
Proposed Sale
200,000$100.47$20.1M—

View →

Mar 10, 2025Mar 10 3:02 PMSwisher Daniel N JR
Proposed Sale
2,200$53.60$117.9K—

View →

Mar 4, 2025Mar 4 6:59 PMGuyer William
Proposed Sale
20,000$59.07$1.2M—

View →

Mar 3, 2025Mar 3 6:47 PMBELANOFF JOSEPH K
Proposed Sale
40,000$60.58$2.4M—

View →

Mar 3, 2025Mar 3 5:37 PMLyon Joseph Douglas
Proposed Sale
5,000$60.58$302.9K—

View →

Mar 3, 2025Mar 3 5:18 PMMaduck Sean
Proposed Sale
20,000$60.58$1.2M—

View →

Feb 10, 2025Feb 10 4:36 PMSwisher Daniel N JR
Proposed Sale
2,200$68.08$149.8K—

View →

Feb 3, 2025Feb 3 6:33 PMMaduck Sean
Proposed Sale
20,000$66.92$1.3M—

View →

Feb 3, 2025Feb 3 6:17 PMLyon Joseph Douglas
Proposed Sale
5,000$66.92$334.6K—

View →

Jan 10, 2025Jan 10 3:49 PMSwisher Daniel N JR
Proposed Sale
2,200$50.54$111.2K—

View →

Jan 2, 2025Jan 2 5:03 PMMaduck Sean
Proposed Sale
20,000$50.39$1.0M—

View →

Jan 2, 2025Jan 2 4:58 PMRobb Gary Charles
Proposed Sale
11,000$50.45$555.0K—

View →

Jan 2, 2025Jan 2 4:52 PMLyon Joseph Douglas
Proposed Sale
5,000$50.34$251.7K—

View →

Dec 10, 2024Dec 10 3:00 PMSwisher Daniel N JR
Proposed Sale
2,200$59.46$130.8K—

View →

Nov 22, 2024Nov 22 7:36 PMLyon Joseph Douglas
Proposed Sale
1,411$56.72$80.0K—

View →

Nov 22, 2024Nov 22 4:41 PMRobb Gary Charles
Proposed Sale
2,609$56.20$146.6K—

View →

Nov 11, 2024Nov 12 1:21 PMSwisher Daniel N JR
Proposed Sale
2,200$59.88$131.7K—

View →

Nov 1, 2024Nov 1 4:55 PMGuyer William
Proposed Sale
10,000$48.97$489.7K—

View →

Oct 1, 2024Oct 1 4:55 PMRobb Gary Charles
Proposed Sale
11,000$46.28$509.1K—

View →

Oct 1, 2024Oct 1 4:44 PMGuyer William
Proposed Sale
10,000$46.28$462.8K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 2, 2026Oct 5 11:58 PMRoberto Wandenkolk VieiraPresident, Oncology
Option Exercise
8,333$21.63133,334(D)

View →

Oct 2, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
9,190$19.2644,167(D)

View →

Oct 1, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
810$13.563,357(D)

View →

Oct 2, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
24,587$8.2741,986(D)

View →

Oct 1, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
413$8.2766,573(D)

View →

Oct 1, 2026Oct 5 11:44 PMJustin Frederick GunnPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Grant/Award
100,000$114.03100,000(D)

View →

Sep 17, 2026Sep 18 11:47 PMGary Charles RobbChief Business Officer
Option Exercise
17,493$8.27182,507(D)

View →

Sep 14, 2026Sep 16 8:30 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
10,000$13.564,167(D)

View →

Sep 1, 2026Sep 4 1:16 AMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.2766,986(D)

View →

Sep 2, 2026Sep 4 1:02 AMRoberto Wandenkolk VieiraPresident, Oncology
Option Exercise
58,333$21.63141,667(D)

View →

Aug 26, 2026Aug 28 8:30 PMKimberly ParkDirector
Option Exercise
30,000$13.4930,000(D)

View →

Aug 25, 2026Aug 27 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
30,955$11.35169,045(D)

View →

Aug 14, 2026Aug 18 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
3,664$8.2791,986(D)

View →

Aug 10, 2026Aug 12 8:27 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
1,031$8.2795,650(D)

View →

Aug 10, 2026Aug 12 8:26 PMWilliam GuyerChief Development Officer
Option Exercise
16,300$21.65110,000(D)

View →

Aug 4, 2026Aug 6 10:44 PMWilliam GuyerChief Development Officer
Option Exercise
3,700$21.65126,300(D)

View →

Aug 3, 2026Aug 5 9:51 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
20,305$8.2796,681(D)

View →

Jul 30, 2026Aug 3 8:30 PMAtabak MokariChief Financial Officer
Option Exercise
80,000$23.0695,833(D)

View →

Jul 15, 2026Jul 17 10:31 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$23.06175,833(D)

View →

Jul 7, 2026Jul 8 11:54 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65130,000(D)

View →

Page 1 of 3

Next →